Vnitr Lek 2016, 62(9):740-745

Jak postupovat při podezření na sekundární arteriální hypertenzi

Tomáš Zelinka1,*, Jiří Widimský jr1, Jiří Ceral2, Jan Filipovský3
1 Centrum pro výzkum, diagnostiku a léčbu hypertenze III. interní kliniky 1. LF UK a VFN v Praze
2 Oddělení preventivní kardiologie I. interní kardioangiologické kliniky LF UK a FN Hradec Králové
3 II. interní klinika LF UK a FN Plzeň

Received: July 11, 2016; Published: September 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zelinka T, Widimský J, Ceral J, Filipovský J. Jak postupovat při podezření na sekundární arteriální hypertenzi. Vnitr Lek. 2016;62(9):740-745.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Mancia G, Fagard R, Narkiewicz K et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31(7): 1281-1357. Dostupné z DOI: <http://dx.doi.org/10.1097/01.hjh.0000431740.32696.cc>. Go to original source... Go to PubMed...
    2. Štrauch B, Petrák O, Zelinka T et al. Precise assessment of noncompliance with the antihypertensive therapy in patients with resistant hypertension using toxicological serum analysis. J Hypertens 2013; 31(12): 2455-2461. Dostupné z DOI: <http://dx.doi.org/10.1097/HJH.0b013e3283652c61>. Go to original source... Go to PubMed...
    3. Rimoldi SF, Scherrer U, Messerli FH. Secondary arterial hypertension: when, who, and how to screen? Eur Heart J 2014; 35(19): 1245-1254. Dostupné z DOI: <http://dx.doi.org/10.1093/eurheartj/eht534>. Go to original source... Go to PubMed...
    4. Sander GE. Secondary hypertension: Drugs and herbal preparations that increase pressure. J Am Soc Hypertens 2014; 8(12): 946-948. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jash.2014.10.006>. Go to original source... Go to PubMed...
    5. Filipovský J, Widimský J, Ceral J et al. Diagnostické a léčebné postupy u arteriální hypertenze - verze 2012. Doporučení České společnosti pro hypertenzi. Vnitř Lék 2012; 58(10): 785-801. Go to PubMed...
    6. Zelinka T. Praktická doporučeníEvropské společnosti pro hypertenzi pro ambulantní monitorování krevního tlaku. Hypertenze & kardiovaskulární prevence 2015; 4(1): 8-12.
    7. Kaplan NM. Primary aldosteronism: evidence against a second epidemic. J Hypertens 2012; 30(10): 1899-1902. < Dostupné z DOI: http://dx.doi.org/10.1097/HJH.0b013e3283559a03>. Go to original source... Go to PubMed...
    8. Funder JW, Carey RM, Fardella C et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008; 93(9): 3266-3281. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2008-0104>. Go to original source... Go to PubMed...
    9. Muxfeldt ES, Margallo V, Costa LM et al. Effects of continuous positive airway pressure treatment on clinic and ambulatory blood pressures in patients with obstructive sleep apnea and resistant hypertension: a randomized controlled trial. Hypertension 2015; 65(4): 736-742. Dostupné z DOI: <http://dx.doi.org/10.1161/HYPERTENSIONAHA.114.04852>. Go to original source... Go to PubMed...
    10. Textor SC, Lerman L. Renovascular hypertension and ischemic nephropathy. Am J Hypertens 2010; 23(11): 1159-1169. Dostupné z DOI: <http://dx.doi.org/10.1038/ajh.2010.174>. Go to original source... Go to PubMed...
    11. Zhu Y, Ren J, Ma X et al. Percutaneous Revascularization for Atherosclerotic Renal Artery Stenosis: A Meta-Analysis of Randomized Controlled Trials. Ann Vasc Surg 2015; 29(7): 1457-1467. Dostupné z DOI: <http://dx.doi.org/10.1016/j.avsg.2015.06.062>. Go to original source... Go to PubMed...
    12. Lenders JW, Duh QY, Eisenhofer G et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2014; 99(6): 1915-1942. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2014-1498>. Go to original source... Go to PubMed...
    13. Biller BM, Grossman AB, Stewart PM et al. Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 2008; 93(7): 2454-2462. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2007-2734>. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.